Related Experiment Videos

Measles and age of vaccination

Insights

Infants under one year old face high measles risk and mortality, especially in developing nations. Lowering the measles vaccination age is crucial for infant protection and disease eradication.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Measles causes significant child morbidity and mortality, particularly in developing countries.
  • Infants are a high-risk group often excluded from current vaccination programs.
  • Maternal immunity wanes after six months, leaving infants susceptible to measles.

Purpose of the Study:

  • To assess measles incidence and mortality in infants under one year in Kuwait.
  • To evaluate the risk of measles in infants compared to older populations.
  • To advocate for adjusting measles vaccination age in developing countries.

Main Methods:

  • Analysis of measles epidemic data from Kuwait between 1976 and 1982.
  • Comparison of measles incidence, caseFatality rates, and mortality in infants versus the general population.
  • Epidemiological data analysis.

Main Results:

  • Infant measles incidence was over five times higher than in the population over one year (758-992 per 100,000 live births).
  • Infants accounted for 13.3-21.7% of total cases and 35% of total deaths.
  • The infant case fatality rate (3.3) was more than double that of the older population (1.4).

Conclusions:

  • Infants under one year represent a vulnerable population with disproportionately high measles morbidity and mortality.
  • Current vaccination schedules may not adequately protect infants, necessitating a review.
  • Lowering the vaccination age for measles is recommended to protect infants and control the disease in developing countries.

Related Concept Videos